Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minoru Tada

Showing results (1-10 of 258) with videos related to

Pageof 26
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|July 5, 2017
Characterization of Therapeutic Monoclonal Antibodies by Using FcγR-expressing Reporter Cell LinesMinoru Tada, Akiko Ishii-Watabe
Proteomics|October 7, 2015
Membrane glycoproteomics of fetal lung fibroblasts using LC/MSDaisuke Takakura, Minoru Tada, Nana Kawasaki
Journal of Pharmaceutical Sciences|November 3, 2019
Fcγ Receptor Activation by Human Monoclonal Antibody AggregatesMinoru Tada, Michihiko Aoyama, Akiko Ishii-Watabe
Mabs|June 13, 2023
Characterization of anti-SARS-CoV-2 monoclonal antibodies focusing on antigen binding, neutralization, and FcγR activation via formation of immune complexMinoru Tada, Michihiko Aoyama, Akiko Ishii-Watabe
Biochemical and Biophysical Research Communications|February 16, 2017
Development of cell-based assay for predictively evaluating the FcγR-mediated human immune cell activation by therapeutic monoclonal antibodiesMichiko Takakura, Minoru Tada, Akiko Ishii-Watabe
Biologicals : Journal of the International Association of Biological Standardization|December 30, 2019
Development of anti-drug monoclonal antibody panels against adalimumab and infliximabTakuo Suzuki, Minoru Tada, Akiko Ishii-Watabe
Methods in Molecular Biology (Clifton, N.J.)|December 13, 2018
A Cell-Based Reporter Assay Measuring the Activation of Fc Gamma Receptors Induced by Therapeutic Monoclonal AntibodiesMichihiko Aoyama, Minoru Tada, Akiko Ishii-Watabe
Journal of Pharmaceutical Sciences|July 1, 2023
Target-independent Immune-cell Activation by Aggregates of T Cell-redirecting Bispecific AntibodiesMinoru Tada, Michihiko Aoyama, Akiko Ishii-Watabe
Biochemical and Biophysical Research Communications|April 10, 2022
FcγRIIIa-158V/F polymorphism affects the performance of FcγRIIIa-related bioassayMichihiko Aoyama, Minoru Tada, Akiko Ishii-Watabe
Mabs|January 9, 2018
Development and characterization of an anti-rituximab monoclonal antibody panelMinoru Tada, Takuo Suzuki, Akiko Ishii-Watabe
Pageof 26

Showing results (1-10 of 258) with videos related to

Sort By:
Pageof 26
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|July 5, 2017
Characterization of Therapeutic Monoclonal Antibodies by Using FcγR-expressing Reporter Cell LinesMinoru Tada, Akiko Ishii-Watabe
Proteomics|October 7, 2015
Membrane glycoproteomics of fetal lung fibroblasts using LC/MSDaisuke Takakura, Minoru Tada, Nana Kawasaki
Journal of Pharmaceutical Sciences|November 3, 2019
Fcγ Receptor Activation by Human Monoclonal Antibody AggregatesMinoru Tada, Michihiko Aoyama, Akiko Ishii-Watabe
Mabs|June 13, 2023
Characterization of anti-SARS-CoV-2 monoclonal antibodies focusing on antigen binding, neutralization, and FcγR activation via formation of immune complexMinoru Tada, Michihiko Aoyama, Akiko Ishii-Watabe
Biochemical and Biophysical Research Communications|February 16, 2017
Development of cell-based assay for predictively evaluating the FcγR-mediated human immune cell activation by therapeutic monoclonal antibodiesMichiko Takakura, Minoru Tada, Akiko Ishii-Watabe
Biologicals : Journal of the International Association of Biological Standardization|December 30, 2019
Development of anti-drug monoclonal antibody panels against adalimumab and infliximabTakuo Suzuki, Minoru Tada, Akiko Ishii-Watabe
Methods in Molecular Biology (Clifton, N.J.)|December 13, 2018
A Cell-Based Reporter Assay Measuring the Activation of Fc Gamma Receptors Induced by Therapeutic Monoclonal AntibodiesMichihiko Aoyama, Minoru Tada, Akiko Ishii-Watabe
Journal of Pharmaceutical Sciences|July 1, 2023
Target-independent Immune-cell Activation by Aggregates of T Cell-redirecting Bispecific AntibodiesMinoru Tada, Michihiko Aoyama, Akiko Ishii-Watabe
Biochemical and Biophysical Research Communications|April 10, 2022
FcγRIIIa-158V/F polymorphism affects the performance of FcγRIIIa-related bioassayMichihiko Aoyama, Minoru Tada, Akiko Ishii-Watabe
Mabs|January 9, 2018
Development and characterization of an anti-rituximab monoclonal antibody panelMinoru Tada, Takuo Suzuki, Akiko Ishii-Watabe
Pageof 26